665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101 - Aix-Marseille Université Access content directly
Journal Articles Annals of Oncology Year : 2021

665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101

M-O. Grimm
  • Function : Author
M. Oya
  • Function : Author
T.K. Choueiri
  • Function : Author
M. Schmidinger
  • Function : Author
D.I. Quinn
  • Function : Author
E. Verzoni
  • Function : Author
A.J.M. van den Eertwegh
  • Function : Author
A. Di Pietro
  • Function : Author
M. Mariani
  • Function : Author
J. Wang
  • Function : Author
D. Thomaidou
  • Function : Author
L. Albiges
  • Function : Author

Dates and versions

hal-03623392 , version 1 (29-03-2022)

Identifiers

Cite

M-O. Grimm, M. Oya, T.K. Choueiri, M. Schmidinger, D.I. Quinn, et al.. 665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101. Annals of Oncology, 2021, 32, pp.S690-S691. ⟨10.1016/j.annonc.2021.08.061⟩. ⟨hal-03623392⟩

Collections

CNRS UNIV-AMU CRCM
7 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More